
Global Galidesivir Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Galidesivir market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Galidesivir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Galidesivir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Galidesivir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Galidesivir include BioCryst Pharmaceuticals, Cayman Chemical, ChemScene, CliniSciences, Taiclone and Xi'an Henrikang Biotech Co., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Galidesivir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Galidesivir.
The Galidesivir market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Galidesivir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Galidesivir Segment by Company
BioCryst Pharmaceuticals
Cayman Chemical
ChemScene
CliniSciences
Taiclone
Xi'an Henrikang Biotech Co.
Galidesivir Segment by Type
Galidesivir Powder
Galidesivir Hydrochloride
Galidesivir Segment by Application
Yellow Fever
Marburg Virus Disease
Filovirus Infections/Ebola Virus Infection
Galidesivir Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galidesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Galidesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galidesivir.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Galidesivir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Galidesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Galidesivir market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Galidesivir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Galidesivir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Galidesivir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Galidesivir include BioCryst Pharmaceuticals, Cayman Chemical, ChemScene, CliniSciences, Taiclone and Xi'an Henrikang Biotech Co., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Galidesivir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Galidesivir.
The Galidesivir market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Galidesivir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Galidesivir Segment by Company
BioCryst Pharmaceuticals
Cayman Chemical
ChemScene
CliniSciences
Taiclone
Xi'an Henrikang Biotech Co.
Galidesivir Segment by Type
Galidesivir Powder
Galidesivir Hydrochloride
Galidesivir Segment by Application
Yellow Fever
Marburg Virus Disease
Filovirus Infections/Ebola Virus Infection
Galidesivir Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galidesivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Galidesivir and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galidesivir.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Galidesivir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Galidesivir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Table of Contents
98 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Galidesivir Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global Galidesivir Sales Estimates and Forecasts (2020-2031)
- 1.3 Galidesivir Market by Type
- 1.3.1 Galidesivir Powder
- 1.3.2 Galidesivir Hydrochloride
- 1.4 Global Galidesivir Market Size by Type
- 1.4.1 Global Galidesivir Market Size Overview by Type (2020-2031)
- 1.4.2 Global Galidesivir Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global Galidesivir Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Galidesivir Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe Galidesivir Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific Galidesivir Sales Breakdown by Type (2020-2025)
- 1.5.4 South America Galidesivir Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa Galidesivir Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 Galidesivir Industry Trends
- 2.2 Galidesivir Industry Drivers
- 2.3 Galidesivir Industry Opportunities and Challenges
- 2.4 Galidesivir Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Galidesivir Revenue (2020-2025)
- 3.2 Global Top Players by Galidesivir Sales (2020-2025)
- 3.3 Global Top Players by Galidesivir Price (2020-2025)
- 3.4 Global Galidesivir Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Galidesivir Major Company Production Sites & Headquarters
- 3.6 Global Galidesivir Company, Product Type & Application
- 3.7 Global Galidesivir Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Galidesivir Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Galidesivir Players Market Share by Revenue in 2024
- 3.8.3 2023 Galidesivir Tier 1, Tier 2, and Tier 3
- 4 Galidesivir Regional Status and Outlook
- 4.1 Global Galidesivir Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global Galidesivir Historic Market Size by Region
- 4.2.1 Global Galidesivir Sales in Volume by Region (2020-2025)
- 4.2.2 Global Galidesivir Sales in Value by Region (2020-2025)
- 4.2.3 Global Galidesivir Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global Galidesivir Forecasted Market Size by Region
- 4.3.1 Global Galidesivir Sales in Volume by Region (2026-2031)
- 4.3.2 Global Galidesivir Sales in Value by Region (2026-2031)
- 4.3.3 Global Galidesivir Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 Galidesivir by Application
- 5.1 Galidesivir Market by Application
- 5.1.1 Yellow Fever
- 5.1.2 Marburg Virus Disease
- 5.1.3 Filovirus Infections/Ebola Virus Infection
- 5.2 Global Galidesivir Market Size by Application
- 5.2.1 Global Galidesivir Market Size Overview by Application (2020-2031)
- 5.2.2 Global Galidesivir Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global Galidesivir Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Galidesivir Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe Galidesivir Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific Galidesivir Sales Breakdown by Application (2020-2025)
- 5.3.4 South America Galidesivir Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa Galidesivir Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 BioCryst Pharmaceuticals
- 6.1.1 BioCryst Pharmaceuticals Comapny Information
- 6.1.2 BioCryst Pharmaceuticals Business Overview
- 6.1.3 BioCryst Pharmaceuticals Galidesivir Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 BioCryst Pharmaceuticals Galidesivir Product Portfolio
- 6.1.5 BioCryst Pharmaceuticals Recent Developments
- 6.2 Cayman Chemical
- 6.2.1 Cayman Chemical Comapny Information
- 6.2.2 Cayman Chemical Business Overview
- 6.2.3 Cayman Chemical Galidesivir Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Cayman Chemical Galidesivir Product Portfolio
- 6.2.5 Cayman Chemical Recent Developments
- 6.3 ChemScene
- 6.3.1 ChemScene Comapny Information
- 6.3.2 ChemScene Business Overview
- 6.3.3 ChemScene Galidesivir Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 ChemScene Galidesivir Product Portfolio
- 6.3.5 ChemScene Recent Developments
- 6.4 CliniSciences
- 6.4.1 CliniSciences Comapny Information
- 6.4.2 CliniSciences Business Overview
- 6.4.3 CliniSciences Galidesivir Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 CliniSciences Galidesivir Product Portfolio
- 6.4.5 CliniSciences Recent Developments
- 6.5 Taiclone
- 6.5.1 Taiclone Comapny Information
- 6.5.2 Taiclone Business Overview
- 6.5.3 Taiclone Galidesivir Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Taiclone Galidesivir Product Portfolio
- 6.5.5 Taiclone Recent Developments
- 6.6 Xi'an Henrikang Biotech Co.
- 6.6.1 Xi'an Henrikang Biotech Co. Comapny Information
- 6.6.2 Xi'an Henrikang Biotech Co. Business Overview
- 6.6.3 Xi'an Henrikang Biotech Co. Galidesivir Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Xi'an Henrikang Biotech Co. Galidesivir Product Portfolio
- 6.6.5 Xi'an Henrikang Biotech Co. Recent Developments
- 7 North America by Country
- 7.1 North America Galidesivir Sales by Country
- 7.1.1 North America Galidesivir Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America Galidesivir Sales by Country (2020-2025)
- 7.1.3 North America Galidesivir Sales Forecast by Country (2026-2031)
- 7.2 North America Galidesivir Market Size by Country
- 7.2.1 North America Galidesivir Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America Galidesivir Market Size by Country (2020-2025)
- 7.2.3 North America Galidesivir Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe Galidesivir Sales by Country
- 8.1.1 Europe Galidesivir Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe Galidesivir Sales by Country (2020-2025)
- 8.1.3 Europe Galidesivir Sales Forecast by Country (2026-2031)
- 8.2 Europe Galidesivir Market Size by Country
- 8.2.1 Europe Galidesivir Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe Galidesivir Market Size by Country (2020-2025)
- 8.2.3 Europe Galidesivir Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific Galidesivir Sales by Country
- 9.1.1 Asia-Pacific Galidesivir Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific Galidesivir Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific Galidesivir Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific Galidesivir Market Size by Country
- 9.2.1 Asia-Pacific Galidesivir Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific Galidesivir Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific Galidesivir Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America Galidesivir Sales by Country
- 10.1.1 South America Galidesivir Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America Galidesivir Sales by Country (2020-2025)
- 10.1.3 South America Galidesivir Sales Forecast by Country (2026-2031)
- 10.2 South America Galidesivir Market Size by Country
- 10.2.1 South America Galidesivir Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America Galidesivir Market Size by Country (2020-2025)
- 10.2.3 South America Galidesivir Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa Galidesivir Sales by Country
- 11.1.1 Middle East and Africa Galidesivir Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa Galidesivir Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa Galidesivir Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa Galidesivir Market Size by Country
- 11.2.1 Middle East and Africa Galidesivir Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa Galidesivir Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa Galidesivir Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 Galidesivir Value Chain Analysis
- 12.1.1 Galidesivir Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Galidesivir Production Mode & Process
- 12.2 Galidesivir Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Galidesivir Distributors
- 12.2.3 Galidesivir Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.